SEK209.20
2.88% day before yesterday
Stockholm, Aug 01, 05:30 pm CET
ISIN
SE0010323311
Symbol
BIOA B

BioArctic AB Stock price

SEK209.20
+31.40 17.66% 1M
-4.80 2.24% 6M
+9.70 4.86% YTD
+42.70 25.65% 1Y
+103.60 98.11% 3Y
+120.40 135.59% 5Y
+180.20 621.38% 10Y
+180.20 621.38% 20Y
Stockholm, Closing price Fri, Aug 01 2025
-6.20 2.88%
ISIN
SE0010323311
Symbol
BIOA B
Industry

Key metrics

Basic
Market capitalization
SEK19.1b
Enterprise Value
SEK18.3b
Net debt
positive
Cash
SEK788.6m
Shares outstanding
88.5m
Valuation (TTM | estimate)
P/E
20.5 | 18.9
P/S
12.6 | 9.9
EV/Sales
12.1 | 9.5
EV/FCF
negative
P/B
9.9
Dividends
DPS
SEK0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
SEK1.5b | SEK1.9b
EBITDA
SEK923.0m | SEK1.2b
EBIT
SEK919.8m | SEK1.1b
Net Income
SEK902.0m | SEK981.6m
Free Cash Flow
SEK-190.1m
Growth (TTM | estimate)
Revenue
501.6% | 646.5%
EBITDA
- | 662.9%
EBIT
859.9% | 612.3%
Net Income
838.3% | 654.3%
Free Cash Flow
-83.3%
Margin (TTM | estimate)
Gross
97.6%
EBITDA
60.8% | 62.0%
EBIT
60.6%
Net
59.4% | 51.1%
Free Cash Flow
-12.5%
Financial Health
Equity Ratio
80.5%
Return on Equity
-19.8%
ROCE
46.7%
ROIC
-
Debt/Equity
0.0
More
EPS
SEK10.2
FCF per Share
SEK-2.1
Short interest
-
Employees
107
Rev per Employee
SEK2.4m
Show more

Is BioArctic AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

BioArctic AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a BioArctic AB forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a BioArctic AB forecast:

Buy
82%
Hold
18%

Financial data from BioArctic AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,517 1,517
502% 502%
100%
- Direct Costs 36 36
14% 14%
2%
1,481 1,481
604% 604%
98%
- Selling and Administrative Expenses 156 156
18% 18%
10%
- Research and Development Expense 333 333
429% 429%
22%
923 923
-
61%
- Depreciation and Amortization 3.13 3.13
-
0%
EBIT (Operating Income) EBIT 920 920
860% 860%
61%
Net Profit 902 902
838% 838%
59%

In millions SEK.

Don't miss a Thing! We will send you all news about BioArctic AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Gunilla Osswald
Employees 107
Founded 2000
Website www.bioarctic.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today